MS-275

Pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate; Entinostat
MS-275 is a potent and selective non-hydroxamate HDAC inhibitor. Considered to be a class I selective inhibitor but displays some selectivity amongst class I members:HDAC1 (IC50 = 0.3 mM); HDAC3 (IC50 = 8 mM) with no inhibition of HDAC8 (at >100 mM)1. Induces hyperacetylation of nuclear histones in tumor cells resulting in inhibition of proliferation of a variety of human tumor cell lines2. Protects p53-deficient mice against ischemic injury3. Suppresses the p38 MAP kinase pathway in rheumatoid arthritic synovial fibroblasts4. Active in vivo.
Physical Properties: Pale yellow powder
MW=376.4 C21H20N4O3
Analysis: >98% (TLC); NMR (Conforms)
Solubilization: May be dissolved in DMSO (25 mg/ml, warm)
Storage: Store desiccated as supplied at -20°C for up to 1 year. Store solutions at -20°C for up to 1 week.
Amount: 5mg